scholarly article | Q13442814 |
P50 | author | Amit Singh | Q37830354 |
P2093 | author name string | Anil K Tyagi | |
C N Paramasivan | |||
P R Narayanan | |||
V D Ramanathan | |||
Radhika Gupta | |||
R A Vishwakarma | |||
P2860 | cites work | Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 |
The Envelope of Mycobacteria | Q22241995 | ||
Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis | Q27730411 | ||
Enzymatic omega-oxidation. IV. Purification and properties of the omega-hydroxylase of Pseudomonas oleovorans | Q28241255 | ||
The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis | Q28486214 | ||
mymA operon of Mycobacterium tuberculosis: its regulation and importance in the cell envelope | Q28486399 | ||
Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates | Q28486598 | ||
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages | Q28486647 | ||
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope | Q28486853 | ||
Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis | Q28486917 | ||
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase | Q28486974 | ||
Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes | Q28487095 | ||
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice | Q28487125 | ||
Mycobacterium tuberculosis genes induced during infection of human macrophages | Q28487178 | ||
A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis | Q28487225 | ||
Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5 | Q28487230 | ||
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment | Q28487339 | ||
The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis | Q28487416 | ||
Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier | Q28487534 | ||
Genetic requirements for mycobacterial survival during infection | Q29547599 | ||
Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. | Q30843747 | ||
The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. | Q33960385 | ||
New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide | Q33966438 | ||
Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide | Q33991596 | ||
Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection | Q34021218 | ||
A novel bifunctional wax ester synthase/acyl-CoA:diacylglycerol acyltransferase mediates wax ester and triacylglycerol biosynthesis in Acinetobacter calcoaceticus ADP1. | Q34167186 | ||
Activation of pyrazinamide and nicotinamide in acidic environments in vitro. | Q34537644 | ||
Mycobacterium and the coat of many lipids | Q34766315 | ||
The biosynthesis of mycolic acids by Mycobacteria: current and alternative hypotheses | Q34778231 | ||
Reevaluation of envelope profiles and cytoplasmic ultrastructure of mycobacteria processed by conventional embedding and freeze-substitution protocols | Q36139238 | ||
A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates | Q36456125 | ||
Isoniazid Inhibition of the Synthesis of Monounsaturated Long-Chain Fatty Acids in Mycobacterium tuberculosis H37Ra | Q36481920 | ||
Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography. | Q36537274 | ||
Sequence of a newly identified Mycobacterium tuberculosis gene encoding a protein with sequence homology to virulence-regulating proteins | Q36780424 | ||
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. | Q37229393 | ||
Gas-chromatographic analysis of mycolic acid cleavage products in mycobacteria | Q37335997 | ||
Enhanced gene replacement in mycobacteria | Q39068296 | ||
Production of mutants in amino acid biosynthesis genes of Mycobacterium tuberculosis by homologous recombination | Q39338617 | ||
High-performance liquid chromatography patterns of Mycobacterium gordonae mycolic acids | Q40187502 | ||
Determination of molecular species composition of C80 or longer-chain alpha-mycolic acids in Mycobacterium spp. by gas chromatography-mass spectrometry and mass chromatography | Q40207691 | ||
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. | Q40793082 | ||
Immunopathogenesis of pulmonary tuberculosis | Q40868525 | ||
Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice | Q40875190 | ||
The structure and function of the isoniazid target in M. tuberculosis | Q41077426 | ||
The envelope layers of mycobacteria with reference to their pathogenicity. | Q41610158 | ||
Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target | Q42149965 | ||
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis | Q42238872 | ||
Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. | Q42541926 | ||
Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. | Q43756344 | ||
Temperature-induced changes in the cell-wall components of Mycobacterium thermoresistibile | Q44170685 | ||
(Omega -2) hydroxylation of fatty acids by a soluble system from bacillus megaterium | Q44579175 | ||
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. | Q44655558 | ||
Mycolic acid structure determines the fluidity of the mycobacterial cell wall | Q44732618 | ||
Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines | Q47999808 | ||
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium | Q48038458 | ||
Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice. | Q52548604 | ||
Separation of C50--60 and C70--80 mycolic acid molecular species and their changes by growth temperatures in Mycobacterium phlei | Q67416543 | ||
Thermally adaptive changes of mycolic acids in Mycobacterium smegmatis | Q69723196 | ||
Regulation of cell wall mycolic acid biosynthesis in acid-fast bacteria. I. Temperature-induced changes in mycolic acid molecular species and related compounds in Mycobacterium phlei | Q71302308 | ||
Distribution of C22-, C24- and C26-alpha-unit-containing mycolic acid homologues in mycobacteria | Q71574650 | ||
Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages | Q74506194 | ||
Preparation of cell-wall fractions from mycobacteria | Q77914557 | ||
THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES | Q78292069 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell wall | Q128700 |
Mycobacterium tuberculosis | Q130971 | ||
P304 | page(s) | 4173-4186 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Journal of Bacteriology | Q478419 |
P1476 | title | Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs | |
P478 | volume | 187 |
Q36845283 | A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes |
Q28473609 | A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine |
Q28475648 | A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen |
Q33360202 | A novel interaction linking the FAS-II and phthiocerol dimycocerosate (PDIM) biosynthetic pathways |
Q36702412 | A vitamin B₁₂ transporter in Mycobacterium tuberculosis |
Q38830420 | Antibiotic resistance mechanisms in M. tuberculosis: an update |
Q37037420 | Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors |
Q42643574 | Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis |
Q47861204 | Characterization of MymA protein as a flavin-containing monooxygenase and as a target of isoniazid. |
Q28486836 | Characterization of an acid inducible lipase Rv3203 from Mycobacterium tuberculosis H37Rv |
Q28472299 | Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis |
Q42673180 | Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis |
Q28550914 | Diversity of Mycobacterium tuberculosis across Evolutionary Scales |
Q37221459 | Does the lipR gene of tubercle bacilli have a role in tuberculosis transmission and pathogenesis? |
Q64095735 | Extended insight into the Mycobacterium chelonae-abscessus complex through whole genome sequencing of Mycobacterium salmoniphilum outbreak and Mycobacterium salmoniphilum-like strains |
Q92304072 | Fatty acylCoA synthetase FadD13 regulates proinflammatory cytokine secretion dependent on the NF-κB signalling pathway by binding to eEF1A1 |
Q33632198 | Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival |
Q89947944 | Genetic and pharmacological inhibition of inflammasomes reduces the survival of Mycobacterium tuberculosis strains in macrophages |
Q38025771 | Genetic engineering of Mycobacterium tuberculosis: a review |
Q93133601 | Genome-wide mutational biases fuel transcriptional diversity in the Mycobacterium tuberculosis complex |
Q27313489 | Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunity |
Q37576576 | Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential. |
Q40037104 | Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection |
Q97646056 | High-Throughput Screen for Cell Wall Synthesis Network Module in Mycobacterium tuberculosis Based on Integrated Bioinformatics Strategy |
Q52688716 | Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. |
Q55403103 | Integrated Multi-Omic Analysis of Mycobacterium tuberculosis H37Ra Redefines Virulence Attributes. |
Q37778480 | Is Mycobacterium tuberculosis stressed out? A critical assessment of the genetic evidence |
Q34680595 | Lipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis |
Q37270749 | Mapping of genotype-phenotype diversity among clinical isolates of mycobacterium tuberculosis by sequence-based transcriptional profiling |
Q38062402 | Molecular biology of drug resistance in Mycobacterium tuberculosis |
Q38429871 | Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs |
Q46156299 | Mutational analysis of the -10 region from the Mycobacterium tuberculosis lipF promoter |
Q38695050 | Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a TH1 response |
Q34747029 | Mycobacterium tuberculosis protein kinase K confers survival advantage during early infection in mice and regulates growth in culture and during persistent infection: implications for immune modulation |
Q28486676 | Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis |
Q35905682 | RD-1 encoded EspJ protein gets phosphorylated prior to affect the growth and intracellular survival of mycobacteria |
Q49493694 | Stress-Induced Reorganization of the Mycobacterial Membrane Domain |
Q36035900 | Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines |
Q28487114 | The Mycobacterium tuberculosis protein kinase K modulates activation of transcription from the promoter of mycobacterial monooxygenase operon through phosphorylation of the transcriptional regulator VirS |
Q28486782 | The acid-induced operon Rv3083-Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages |
Q38053069 | Virulence factors of the Mycobacterium tuberculosis complex |
Search more.